URGENTLY REQUIRED
Are you looking to work in a global growth company where you can make a real difference? With more than 100,000 associates around the globe in our affiliates in over 140 countries, we share a vision of a better today and tomorrow for patients – a vision that drives our growth and success. Our greatest job satisfaction is knowing that we improve lives, we extend lives, and we save lives – and we do it with increasing precision and efficiency through breakthrough science and innovation.
MEDICAL SCIENTIFIC LIASON You will be accountable to build scientific partnerships with healthcare professionals and decision makers to build advocacy, strategically prepare and support the development, launch and commercialization of drug products through education of Key Stakeholders/ Key Opinion Leaders (KOL), education of the scientific community and KOLs, clinical trial support, and by the scientific exchange seeking external insight to shape Novartis commercial and development programs. Your Qualification:- Medical Doctor, preferably from reputable University
- 1-2 years experience in pharma industry is an advantage
- Thorough knowledge of clinical medicine, disease management, and medical research in at least one therapeutic area.
- Ability to synthesize recent scientific information, analyze them within strategic and regulatory settings.
- Strong personal integrity, and customer focus.
- Excellent interpersonal communication, negotiation and advanced presentation skills.
- Effectively contribute to work on multifunctional teams.
- Must be able to adapt, organize, prioritize, and work effectively in a constantly changing field-based environment.
- Willing to travel extensively throughout Indonesia.
- Proven ability to develop and foster peer-to-peer, credible relationships in order to educate and negotiate Key Opinion Leaders/decision makers.
- Excellent in English both verbal and writing
or Mail to:
PT. Novartis IndonesiaWisma BNI 46, 35th floorJl. Jend. Sudirman Kav.1 Jakarta 10220
Only short listed candidates will be notified